Haixia Zhou

3PUBLICATIONS
10CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Oct 28, 2025
IL-6 knockdown anti-CD19 CAR-T cells (ssCART-19) for patients with relapsed or refractory acute lymphoblastic leukemia: phase 1 trial.

Sheng-Li Xue, Mei-Jing Liu, Chong-Sheng Qian

|Jan 18, 2024
Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in relapsed/refractory acute myeloid leukemia: results of a pilot study.

Yan-Yan Li, Shuai-Shuai Ge, Yuan-Hong Huang

|Dec 16, 2023
miR-181a plays the tumor-suppressor role in chronic myeloid leukemia CD34 + cells partially via SERPINE1.

Xiuyan Zhang, Wenjuan Ma, Wen Xue

Pageof 1

Frequent Collaborators

2 joint publications

Sheng-Li Xue

2 joint publications

Hai-Ping Dai

1 joint publications

Shuai-Shuai Ge

1 joint publications

Yuan-Hong Huang